Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.54
$0.0030.20%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 214.35% | 161.25% | 317.48% | 487.50% | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 214.35% | 161.25% | 317.48% | 487.50% | -- |
Cost of Revenue | 1,083.67% | 708.33% | 1,025.00% | 715.38% | -- |
Gross Profit | -40.72% | 2.42% | 102.53% | 377.78% | -- |
SG&A Expenses | -8.55% | 1.58% | -15.40% | -7.20% | 4.89% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -3.44% | -11.96% | -15.80% | -8.87% | -5.13% |
Operating Income | 9.75% | 15.37% | 19.62% | 11.16% | 7.80% |
Income Before Tax | 16.10% | 8.95% | 13.56% | 4.64% | 1.07% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 16.10% | 8.95% | 13.56% | 4.64% | 1.07% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 16.10% | 8.95% | 13.56% | 4.64% | 1.07% |
EBIT | 9.75% | 15.37% | 19.62% | 11.16% | 7.80% |
EBITDA | 9.55% | 15.19% | 19.46% | 10.95% | 7.54% |
EPS Basic | 24.84% | 16.25% | 22.22% | 15.72% | 14.48% |
Normalized Basic EPS | 19.93% | 22.33% | 26.69% | 19.26% | 17.24% |
EPS Diluted | 24.84% | 16.25% | 22.22% | 15.72% | 14.48% |
Normalized Diluted EPS | 19.93% | 22.33% | 26.69% | 19.26% | 17.24% |
Average Basic Shares Outstanding | 12.08% | 10.04% | 9.94% | 10.64% | 13.42% |
Average Diluted Shares Outstanding | 12.08% | 10.04% | 9.94% | 10.64% | 13.42% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |